Lallemand Inc, a global leader within industrial biotechnology headquartered in Montreal (Canada), confirmed the closing in December 2023 of the acquisition by its subsidiary Danstar Ferment AG of Swiss biotechnology business Evolva AG from Evolva Holding AG. The transaction which was originally announced to the Swiss Stock Exchange on 21 November 2023 was approved by Evolva Holding shareholders at an extraordinary general meeting on 21st December 2023.
Swiss-based biotech company Evolva teams up with Paris-based FCI to expand the European sales, marketing and distribution of its high-purity, sustainably sourced citrus ingredients, nootkatone and valencene.
IL BIOECONOMISTA 